For the Inventor, By the Inventor

Enter assignee name

Chirotech Technology Limited

USPTO Granted Patents = 30

% Expired Patents = 20.0

EPO Patents = 2

Forward Citations = 44

Loading Chart...

Loading Chart...

38 inventors (with patents filed for the assignee):

Mark Joseph Burk (6 out of 145 patents)

Martin Edward Fox (5 out of 7 patents)

Antonio Zanotti-Gerosa (4 out of 25 patents)

4. Ian Campbell Lennon (4 out of 7 patents)

5. Gerard Andrew Potter (3 out of 13 patents)

6. Richard Anthony Wisdom (3 out of 6 patents)

7. Brian Michael Adger (3 out of 5 patents)

8. Raymond McCague (3 out of 13 patents)

9. Ulrich Berens (3 out of 3 patents)

10. Arne Gerlach (2 out of 2 patents)

11. Christophe Guillaume Malan (2 out of 2 patents)

12. Julian Henschke (2 out of 2 patents)

13. Ulrich Berens (2 out of 2 patents)

14. Caroline Susan Lee (2 out of 3 patents)

15. Frank Bienewald (2 out of 2 patents)

Core Competencies:

Asymmetric Hydrogenation

Chiral Ligands

Phosphorus Ligands

Selective Catalysis

Cyclopentenes

Prostaglandins

Stereoselective Hydrolysis

Enantiomers

Transition Metals

Ferrocene Catalysts

Arylphosphines

Lactamase Enzyme

30 patents: Sort by Forward Citations

1. 6897324 - Process for the preparation of 11-oxaprostaglandins and intermediates therein (2005-05-24),

2. 6841499 - Supported ferrocene-based catalysts for selective aldehyde hydrogenation (2005-01-11),

3. 6613922 - Phosphorus p-cyclophane ligands and their use in transition metal catalyzed asymmetric reactions (2003-09-02),

4. 6593489 - Substituted cyclopentenes, their preparation and their use for chiral scaffolds (2003-07-15),

5. 6545183 - Process for preparing cyclic phosphines (2003-04-08),

6. 6528687 - Ruthenium complexes and their use in asymmetric hydrogenation (2003-03-04),

7. 6508753 - Chiral ligands for asymmetric catalysis (2003-01-21),

8. 6486347 - Preparation of phosphine ligands (2002-11-26),

9. 6486337 - Ruthenium-disphosphine complexes and their use as catalysts (2002-11-26),

10. 6479694 - Preparation of chiral cis-5-amino-2-cyclopenten-1-ol derivatives (2002-11-12),

11. 6437152 - Intermediate for the synthesis of prostaglandins (2002-08-20),

12. 6423522 - Microorganism lactamase enzyme obtained therefrom and their use (2002-07-23),

13. 6414187 - Asymmetric hydrogenation (2002-07-02),

14. 6320068 - Preparation of arylphosphines (2001-11-20),

15. 6313320 - Process for the preparation of calanolide precursors (2001-11-06),

Chirotech Technology Limited is a UK-based organization specializing in the development and manufacturing of innovative pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company focuses on providing advanced solutions for the pharmaceutical industry, leveraging its expertise in chemical synthesis and process development. With a commitment to quality and regulatory compliance, Chirotech plays a crucial role in supporting drug development and production, contributing to the advancement of healthcare solutions globally.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

30 Patents

#23 in

#593 in United Kingdom

#21,853 in the World

Chirotech Technology Limited

Forward Citations = 44

38 inventors:

Mark Joseph Burk (6 out of 145 patents)

Martin Edward Fox (5 out of 7 patents)

Antonio Zanotti-Gerosa (4 out of 25 patents)

4. Ian Campbell Lennon (4 out of 7 patents)

5. Gerard Andrew Potter (3 out of 13 patents)

Please report any incorrect information to [email protected]

Loading…